These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16783989)

  • 41. [Tablet treatment of diabetes mellitus: indications and adverse effects of oral antidiabetics].
    Zix R
    Landarzt; 1968 Mar; 44(7):333-7. PubMed ID: 5717372
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antidiabetic agents].
    Oudart N
    Rev Infirm; 1999 May; (49):20-6. PubMed ID: 10652870
    [No Abstract]   [Full Text] [Related]  

  • 43. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical experiences with administration of oral antidiabetic agent Buformin].
    Sieberová R
    Cas Lek Cesk; 1971 Apr; 110(18):420-1. PubMed ID: 5574346
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antidiabetic drugs and in-patient admissions attributable to diabetes in Portugal].
    Gouveia M; Laires P; Borges M; Augusto M; Martins AP
    Acta Med Port; 2012; 25(5):323-31. PubMed ID: 23211204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolinase--a new oral antidiabetic drug.
    Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398
    [No Abstract]   [Full Text] [Related]  

  • 47. Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease.
    Henry RR
    Curr Med Res Opin; 2008 Aug; 24(8):2189-202. PubMed ID: 18573228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prescription of insulin glargine in primary care practices in Germany.
    Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled insulin: new technology, new possibilities.
    Bellary S; Barnett AH
    Int J Clin Pract; 2006 Jun; 60(6):728-34. PubMed ID: 16805759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New classes of drugs in the pipeline. New in the treatment of diabetes mellitus].
    Steri R; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Mar; 39(2):142-6. PubMed ID: 20196042
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacologic management of type 2 diabetes: a review for dentistry.
    Little JW; Rhodus NL
    Gen Dent; 2007; 55(6):564-71; quiz 572-3, 599-600. PubMed ID: 18050585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consulting on the patient with type 2 diabetes: matching medication to disease mechanism.
    Manag Care; 2007 Jun; 16(6 Suppl 5):2-11. PubMed ID: 17703795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES
    Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fenfluramine as an oral antidiabetic].
    Hepp KD
    MMW Munch Med Wochenschr; 1983 Nov; 125(46):126-7. PubMed ID: 6417535
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mechanism of therapeutic effect of antidiabetic sulfanilamide drugs].
    Beliaeva MM; Shlimovich PB
    Sov Med; 1976 Jun; (6):138-9. PubMed ID: 1019714
    [No Abstract]   [Full Text] [Related]  

  • 58. Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
    Barnett A
    Int J Clin Pract Suppl; 2007 Aug; (154):12-8. PubMed ID: 17593273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Modern oral sugar-reducing drugs: focus to glibenclamide].
    Ushakova EA
    Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
    [No Abstract]   [Full Text] [Related]  

  • 60. Research progress on anti-diabetic Chinese medicines.
    Li YJ; Xu HX
    Zhong Yao Cai; 2006 Jun; 29(6):621-4. PubMed ID: 17039886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.